Track papers across labs, topics, and trends.
Search papers, labs, and topics across Lattice.
This paper addresses the challenge of optimizing recovery pathways in autonomous materials discovery by framing it as a sequential decision-making problem that incorporates both pathway identification and continuous optimization under varying experimental costs. The authors introduce Coactive learning, which integrates a cost-sensitive Bayesian hypothesis-discrimination policy with Gaussian-process Bayesian optimization, achieving performance comparable to oracle-pathway references without requiring oracle labels. The method effectively navigates the complexities of pathway selection, demonstrating its robustness in avoiding suboptimal commitments in experimental setups, as evidenced by evaluations on synthetic benchmarks and real-world data from PNNL's CICERO study.
Cost-aware optimization can significantly enhance the efficiency of autonomous materials discovery, avoiding costly missteps in pathway selection.
Autonomous laboratories automate experimental execution, but a campaign must also decide which recovery pathway merits optimization. We formulate this as a sequential decision problem with a discrete pathway-identification stage and a continuous within-pathway optimization stage under heterogeneous experimental costs. Our implementation, Coactive learning, combines a cost-sensitive Bayesian hypothesis-discrimination policy motivated by EC2 (Golovin et al., 2010) with Gaussian-process Bayesian optimization (Srinivas et al., 2010). Under explicitly stated assumptions, the expected spend of one fixed-budget campaign attempt is bounded by the expected pathway-identification cost plus the capped within-pathway optimization budget. We evaluate the method on synthetic benchmarks constrained by selected results reported for PNNL's CICERO selective-precipitation study (Ritchhart et al., 2026). The method performs comparably to an oracle-pathway Bayesian-optimization reference and to a strong split-plate baseline that discriminates pathways with its first plate, without receiving an oracle label for the correct pathway. It is given a candidate hypothesis space and a diagnostic likelihood model. On an NdFeB-inspired instance, it avoids the simulated penalty of a commit-first baseline that initially selects a plausible but inferior hydroxide pathway. This hypothetical wrong-first-commitment scenario is motivated by the hydroxide-oxalate performance contrast reported by CICERO. We characterize the sensitivity of these conclusions to the assumed cost model. The code and benchmark are open source.